Abstract
Sleeping sickness is caused by trypanosome parasites, which infect humans and livestock in Sub-Saharan Africa. Haem is an important growth factor for the parasites and is acquired from the host by receptor-mediated uptake of haptoglobin (Hp)–haemoglobin (Hb) complexes. The parasite Hp–Hb receptor (HpHbR) is also a target for a specialized innate immune defence executed by trypanosome-killing lipoprotein particles containing an Hp-related protein in complex with Hb. Here we report the structure of the multimeric complex between human Hp–Hb and Trypanosoma brucei brucei HpHbR. Two receptors forming kinked three-helical rods with small head regions bind to Hp and the β-subunits of Hb (βHb), with one receptor at each end of the dimeric Hp–Hb complex. The Hb β-subunit haem group directly associates with the receptors, which allows for sensing of haem-containing Hp–Hb. The HpHbR-binding region of Hp is conserved in Hp-related protein, indicating an identical recognition of Hp–Hb and trypanolytic particles by HpHbR in human plasma.
Similar content being viewed by others
Introduction
Sleeping sickness is caused by infection of humans and livestock by various forms of Trypanosoma brucei (T.b.) parasites and is a major health and socio-economical problem in large areas of Sub-Saharan Africa1. The parasites are protozoan hemoflagellates transmitted by tsetse flies to the host blood where they proliferate. Evasion of the host immune system is achieved by antigenic variation, in which a coating of variable surface glycoproteins (VSGs) on the parasite surface is constantly changing within the population2,3. Trypanosomes are deficient in haem biosynthesis and require uptake of exogenous haem4. Haem acquisition is mediated by the haptoglobin (Hp)–haemoglobin (Hb) receptor (HpHbR) located in the flagellar pocket of the parasite5. The receptor recognizes and takes up the Hp–Hb complex formed in the host’s bloodstream when Hb is released from erythrocytes during haemolysis. The trypanosome parasites themselves are reported to possess haemolytic activity6. This allows the parasite to steal the haem groups from Hb for incorporation into its own haemoproteins5. HpHbR is a 37-kDa receptor5 structurally related to the glycophosphatidylinositol (GPI)-anchored trypanosomal VSGs7 and the glutamic acid/alanine-rich protein, GARP, which replaces the VSGs in the tsetse midgut8. On the other hand, HpHbR is completely different from the mammalian Hp–Hb receptor, CD1639. Besides its role in haem acquisition, HpHbR is also a target for primate innate immunity against certain trypanosome species10. In humans this is achieved through the action of trypanolytic particles (TLF1 or TLF2) that contain the primate-specific apolipoprotein L1 and Hp-related protein (Hpr)11,12,13. Hpr is a gene duplication product highly homologous to Hp14. TLF1 particles enter the parasite via HpHbR-mediated uptake15. The uptake of TLF1 requires Hb, which interacts with Hpr to form an Hpr–Hb complex16. As HpHbR, in contrast to CD163, also recognizes Hpr–Hb5, the entire TLF1 particle is endocytosed by the parasite17. Subsequently, apolipoprotein L1 forms a pore in the lysosomal membrane leading to a lethal release of lysosomal content into the parasite cytosol18,19,20,21. The two human pathogenic subspecies Trypanosoma brucei rhodesiense (T.b. rhodesiense) and Trypanosoma brucei gambiense (T.b. gambiense) express resistance proteins counteracting apolipoprotein L1 activity enabling these parasite strains to evade the lethal action of TLF particles22,23,24,25. T.b. gambiense also exhibits low-level HpHbR expression26 and harbours a L210S substitution in HpHbR, leading to reduced TLF1 uptake7,27,28. These defence mechanisms are not present in the widespread Trypanosoma brucei brucei (T.b. brucei) subspecies, which is highly infectious in many non-primate species that do not express Hpr and apolipoprotein L.
To investigate the mechanism of trypanosomal haem acquisition by HpHbR and its role in human immunity, we have determined the structure of the T.b. brucei HpHbR in complex with human Hp–Hb. The structure reveals an unexpected haem-sensing mechanism of HpHbR that appears conserved in trypanosome species. Furthermore, we show that the Hp–Hb epitope recognized by HpHbR is identical in TLF-associated Hpr–Hb, which explains the inability of trypanosomes to distinguish between the beneficial Hp–Hb and the lethal TLF1 particle.
Results
Structure determination
For structural and functional analysis of the Hp–Hb–HpHbR complex, we purified Hp and Hb from human blood, while HpHbR (residues 36–378) was expressed in the yeast Pichia pastoris. Initial crystallization trials of the complex were unsuccessful. However, when the Hb-binding NEAT1 domain of Staphylococcus aureus IsdH was added to the complex, crystallization was achieved and data extending to 3.1 Å resolution were collected (Table 1; Supplementary Fig. 1). The IsdH fragment appears to stabilize the complex and promote crystal formation by introducing crystal contacts (Supplementary Fig. 2). IsdH NEAT1 interacts exclusively with the α-subunit of Hb (αHb) and is located distal to the receptor interface.
Structure of the Hp–Hb–HpHbR complex
Hp (isoform 1) is a bivalent molecule owing to the association of its complement control protein (CCP) domains29. Each Hp moiety forms a tight interaction with an αβHb-dimer via its serine protease-like (SP) domain and the Hp–Hb complex has a barbell-like structure with αβHb loaded at the ends30,31. Our structure reveals that the dimeric Hp–Hb is recognized by two HpHbR receptors interacting with both the Hp SP domains and the β-subunits of Hb (Fig. 1a,b). The receptors are oriented perpendicular to the longitudinal axis of the Hp–Hb dimer with the membrane-associated ends pointing in the same direction, showing that two receptors are capable of cross-linking the ligand on the surface of trypanosome parasites. This avidity effect is likely to substantially increase the functional affinity of the interaction. A model of trimeric Hp(isoform 2)–Hb30 bound to HpHbR supports that higher multimers of Hp–Hb that are present in humans carrying the Hp2 gene can also bind multiple receptors on the parasite surface (Supplementary Fig. 3). These multimers may have even higher functional affinity for the receptors.
HpHbR residues 36–296 adopt a rod-like structure with a length of 110 Å and approximate diameter of 15 Å (Fig. 1c,d). It is composed of three long helices (I, II and VI) with two small helices (III and IV) forming a bulging head region at the membrane-distal end. No electron density is observed for the C-terminal region (residues 297–378), which is linked to the membrane via a GPI anchor, indicating a flexible or disordered structure. A single disulphide bridge (Cys49–Cys197) connects helices I and III and thereby provides stability to the head region. The structure of T.b. brucei HpHbR is highly similar to the recently described structure of T. congolense HpHbR7(Fig. 1d) and 202 Cα atoms can be superimposed with a r.m.s.d. of only 2.2 Å. However, the two structures differ in the conformation of the membrane-associated end. T.b. brucei HpHbR has a bent conformation due to kinking of helices I, II and VI, whereas T. congolense HpHbR has a straight conformation. Furthermore, the C-terminal extension (T.b. brucei HpHbR residues 297–378) is substantially shorter in T. congolense HpHbR (residues 272–275) (Fig. 1d,e). The difference in length may correlate with difference in thickness of the VSG coat in T.b. brucei and T. congolense, allowing both receptors to extend above the VSGs for interaction with Hp–Hb7.
Binding interfaces
The Hp–Hb–HpHbR structure also for the first time reveals the structure of the human Hp–Hb complex that has previously failed to form high-resolution diffracting crystals32. The human Hp–Hb is essentially similar to the recently determined porcine Hp–Hb complex30 with two CCP domains merging into a CCP fusion domain via β-strand swapping (Fig. 1a). Hp–Hb binds along the side of HpHbR and interacts primarily with residues from helices I and II (Fig. 2a; Supplementary Fig. 4). The Hp-binding site on HpHbR is formed by residues from helix I (residues 68–85) and two residues from helix VI (residues 256 and 259), whereas the βHb-binding site is formed by residues from both helix I (residues 56–70) and helix II (residues 157–165) (Fig. 2a; Supplementary Fig. 4). Furthermore, residues from the loop region between helices III and IV (residues 200–202) also contact βHb. The interface between HpHbR and Hp buries a 1,618-Å2 surface area, whereas the interface between HpHbR and βHb buries 1,491 Å2. In total, the interaction between Hp–Hb and HpHbR buries a 3,013-Å2 surface area.
Several surface-exposed loops from Hp are involved in binding to HpHbR. These are exclusively located in the second β-barrel subdomain of the serine protease-like domain, except for a single residue in the C-terminal part of the Hp α-chain (Asn157). In addition to van der Waals contacts, electrostatic interactions are formed between Hp Lys270 and HpHbR Glu259, Hp Asp305 and HpHbR Lys85 and Hp Glu365 and HpHbR Lys256 (Fig. 2c; Supplementary Fig. 4). Hydrogen bonds are formed between Hp Asn157 and the main chain carbonyl of Thr68 and between Hp Lys345 and HpHbR Ser73. Also, the main chain carbonyl of Gly276 forms a hydrogen bond with HpHbR Gln75. HpHbR recognizes residues from βHb helices C, E and F. From βHb helix C, Arg40 engages in electrostatic interactions with HpHbR Glu70 (Fig. 2d; Supplementary Fig. 4), whereas the main chain carbonyl of C-helix residue Ser44 forms a hydrogen bond with HpHbR Ser161. Lys59 from βHb helix C forms electrostatic interactions with HpHbR Glu165 and a hydrogen bond with HpHbR Ser161. From βHb F-helix, Lys95 form electrostatic interactions with HpHbR Glu57 and a hydrogen bond with the main chain carbonyl of HpHbR Ser202 (Fig. 3a; Supplementary Fig. 4).
Haem-sensing mechanism of HpHbR
HpHbR specifically recognizes the βHb haem prosthetic group via electrostatic interactions between the two basic HpHbR residues Lys56 and Lys164 and the 7-propionate side chain of the haem group (Fig. 3a; Supplementary Fig. 5). HpHbR Lys164 coordinates the carboxylate of the haem 7-propionate side chain with a distance of 2.9 Å, whereas the distance between Lys56 and the carboxylate is 3.5 Å. To test the significance of the HpHbR recognition of the βHb haem group, we prepared samples of apoHb (without haem) by acid acetone precipitation of native human Hb (Supplementary Fig. 6). Similar to native haem-containing Hb, apoHb forms a stable complex with Hp. Using surface plasmon resonance (SPR) with immobilized HpHbR, we show that Hp–apoHb binding to HpHbR is significantly reduced compared with native Hp–Hb (Fig. 3b). However, when hemin is added to Hp–apoHb the binding to HpHbR is partly restored. These results indicate that the interaction between the haem 7-propionate side chain and HpHbR is important for ligand binding. To further test this hypothesis, we mutated HpHbR residues Lys56 and Lys164 that interact directly with the 7-propionate side chain. The HpHbR K164A mutation shows the same binding properties to immobilized Hp–Hb as wild-type HpHbR, whereas the K56A mutation significantly reduces Hp–Hb affinity (Fig. 3c). These results show that both presence of haem on Hb and HpHbR Lys56 are important for the interaction between Hp–Hb and HpHbR, suggesting that direct recognition of the βHb haem group may be of functional importance for haem acquisition by trypanosome parasites. Although Lys164 is located closer to the haem 7-propionate side chain than Lys56 and may engage in a stronger interaction, our results show that it is not important for the interaction between Hp–Hb and HpHbR. HpHbR Ser59 possibly forms a hydrogen bond with the haem 7-propionate side chain, however, its electron density is not well defined suggesting a flexible conformation (Supplementary Fig. 5). Furthermore, the HpHbR S59A mutant shows no decrease in Hp–Hb affinity (Supplementary Fig. 7), indicating no functional significance of Ser59.
Reduced Hp–Hb affinity of T.b. gambiense HpHbR
A single amino-acid difference in T.b. gambiense HpHbR (Ser210) compared with T.b. brucei HpHbR (Leu210) leads to reduced affinity for human Hp–Hb and Hpr–Hb7,27,28. In combination with low-level expression of HpHbR26 and the protective effect of TgsGP22, this evolutionary amino-acid substitution contributes to T.b. gambiense resistance against the human TLF particles. In T.b. brucei, Leu210 is positioned in HpHbR helix IV and its side chain is packed in the hydrophobic core of the head region (Fig. 4). Substitution of leucine to serine at this position probably leads to an overall destabilization of the head region. In addition, HpHbR Leu210 is located only 8 Å from Lys56. Hence the L210S substitution may directly affect the structural properties of Lys56 and consequently the interaction with Hp–Hb and Hpr–Hb associated with TLF particles.
Discussion
Trypanosome parasites are experts in host immune system avoidance due to the VSGs that cover their surface. Only one form of VSG is expressed at a time, but the VGSs are constantly changing within the parasite population by means of gene conversion3, allowing the parasite to escape the adaptive immune system of the host. The VSGs forms an ~150-Å-thick tightly packed monolayer that prevents immunoglobulin recognition of epitopes embedded in the layer33,34,35. To bind and endocytose Hp–Hb or TLF particles, it has been suggested that HpHbR extends above the VSG layer7. In this paper, we present the structure of T.b. brucei HpHbR in complex with Hp–Hb, showing the exact binding site of Hp–Hb along the side of HpHbR. The Hp–Hb-binding site is located ~55 Å from the C-terminal end of HpHbR helix VI, which is connected to the membrane via an 82 amino-acid linker and a GPI anchor. We do not observe any electron density for this C-terminal linker region, probably because it is highly flexible. For the Hp–Hb-binding site to be presented above the VSG layer, the C-terminal linker region must span a distance of >95 Å. Considering the large number of amino acids constituting the linker, a length of 95 Å is achievable. With a ligand-binding region protruding from the VSGs a large part of HpHbR will be accessible from the host’s bloodstream and make the parasite susceptible to immunoglobulin attack. However, restricted access to the flagellar pocket where HpHbR is located and rapid endocytosis followed by antibody degradation may protect the parasite.
Our structural analysis identified an unexpected interaction between HpHbR and the prosthetic haem group bound to βHb. Two HpHbR lysine residues Lys56 and Lys164 both engage in electrostatic interactions with the 7-propionate side chain of βHb haem. Affinity quantification by SPR analysis showed that mutation of Lys56 and removal of haem from Hb had a significant effect on binding, while mutation of Lys164 had no effect. On the basis of these results, we propose that HpHbR Lys56 serves as a haem sensor that enables HpHbR to discriminate between haem-associated Hp–Hb complexes and the corresponding apoprotein. Sequence conservation in an alignment of HpHbR from T. vivax, T. congolense and T.b. brucei mapped on the surface of HpHbR, shows moderate conservation among the three species (Fig. 5a; Supplementary Fig. 8). This includes the Hp–Hb-binding interface. However, the three residues Ser59, Lys164 and Asp168 are strictly conserved within the three species, whereas Lys56 is replaced by an alanine in T. congolense HpHbR or a serine in T. vivax HpHbR. Thus, the important role of T.b. brucei HpHbR Lys56 in ligand recognition is not conserved among trypanosome species. In T. congolense, HpHbR residues Ser59, Lys164 and Asp168 (Ser52, Lys153 and Asp157 in T. congolense HpHbR) are all essential for interaction with HpHbR7. Hence, it appears that the haem-sensing function of Lys56 may have shifted to Lys164 in T. congolense and T. vivax HpHbR. The essential roles of Ser59 and Asp168 in T. congolense HpHbR can be explained by their coordination of Lys164, which may stabilize the position of Lys164 and promote its interaction with the haem 7-propionate side chain (Fig. 5b). T.b. brucei HpHbR Ser59 coordinate Lys56 indicating a similar function of Ser59 in T.b. brucei and T. congolense. However, this is contradicted by our data showing that the S59A mutation in T.b. brucei HpHbR does not decrease its affinity for Hp–Hb. The specific role of T.b. brucei Asp168 in Hp–Hb binding could not be analysed, as the D168A mutant renders the protein unstable.
To our knowledge, HpHbR is the first identified endocytic receptor that directly senses the presence of a prosthetic group within a carrier protein. Other endocytic receptors are able to detect prosthetic groups bound to their ligands, but in an indirect way. The mammalian endocytic receptor cubam that via its cubilin subunit is responsible for intestinal uptake of vitamin B12, a metal-binding haem-like tetrapyrrole, only recognizes the carrier protein, intrinsic factor, when it is in complex with vitamin B12 (ref. 36). In this case vitamin B12 indirectly promotes interaction with cubilin by locking the intrinsic factor in a specific conformation that allows a dual-point interaction with cubilin37.
HpHbR is, as mentioned, also targeted by the human innate immune system via Hpr, which is incorporated in the trypanosome-killing TLFs. The gene encoding Hpr has arisen by a duplication of the Hp gene in primate evolution38. The Hpr amino-acid sequence is 91% identical to Hp, and the two proteins are predicted to have nearly identical three-dimensional structures30. Despite their structural similarity and common ability to bind Hb, Hp and Hpr serve quite different biological functions. Hp is responsible for binding and neutralizing the toxic Hb released from red blood cells and subsequent scavenging by macrophages via its interaction with the receptor CD163 (refs 9, 39), whereas Hpr in complex with Hb mediates delivery of toxic TLF particles to trypanosome parasites16,17.
Our data reveal, in atomic detail, the interaction between Hp and HpHbR, and an alignment of Hp and Hpr shows that residues interacting with HpHbR are conserved (Fig. 6a; Supplementary Fig. 9). Therefore, Hp–Hb and Hpr–Hb most likely form identical interactions with HpHbR, and the structure of the Hp–Hb–HpHbR complex therefore applies to both the haem acquisition mechanism and the human innate immunity against trypanosome parasites (Fig. 6b). As the structural epitopes presented to the parasites by Hp–Hb and Hpr–Hb contained in TLF particles are identical, the parasites are incapable of distinguishing between the beneficial Hp–Hb complex and the lethal TLF particles. On the other hand, the Hp interface with HpHbR is completely distinct from the Hp region known to interact with the mammalian Hp–Hb receptor, CD163 (Fig. 6a). The interaction with CD163 involves two basic Hp-specific residues (Arg311 and Lys321) located in the loop 3 region40. These residues engage in a common type electrostatic and calcium-dependent binding to the scavenger receptor cysteine-rich domains of CD163 (refs 41, 42). These two essential basic residues are not present in Hpr and consequently Hpr–Hb is not recognized by CD163 (ref. 41). This prevents an unfavourable CD163-mediated clearance of TLFs from circulation, while HpHbR-mediated uptake of TLF1 by infecting trypanosome parasites is maintained.
Treatment of human sleeping sickness caused by T.b. gambiense and T.b. rhodesiense is currently restricted to drugs developed over four decades ago43,44. Although efficacious in some cases, these drugs are far from ideal due to the complexity in their medical administration as well as emerging resistance. Consequently, the development of new medical treatments is needed. The new insight into the molecular ligand recognition by the HpHbR may provide a framework for design of compounds that target HpHbR. One tempting approach is to exploit HpHbR for delivery of toxic and parasite-killing compounds to the parasite. Another approach is to design compounds that inhibit HpHbR-medidated Hp–Hb uptake and thereby restrict parasite haem acquisition and growth.
Methods
Purification of Hp–Hb from human blood
Anti-coagulant (trisodium citrate and EDTA) was added to human blood (from a homozygotic Hp1 donor) to a final concentration of 15 mM (trisodium citrate) and 0.15 mM (EDTA). Plasma and blood cells were separated by centrifugation at 4,000 g for 20 min. The blood cell fraction was lysed by addition of water (1:1 ratio) and cell debris was removed by centrifugation at 8,000 g for 15 min. Clotting factors were removed from plasma by addition of 80 mM BaCl2, followed by incubation on ice for 1 h and centrifugation at 27,000 g for 15 min. Serum and blood cell fractions were stored at −80 °C. Thawed serum and blood cell fractions were mixed in a ratio of 25:1 and incubated at 4 °C overnight. The sample was diluted 1:2 in 20 mM Tris–HCl pH 7.6 and loaded on a Blue Sepharose Fast Flow column (GE healthcare) equilibrated in 50 mM KCl, 20 mM Tris–HCl pH 7.6. The flow-through was collected and loaded on a Q Sepharose Fast Flow column (GE Healthcare) equilibrated with buffer Q-A (50 mM KCl, 20 mM Tris–HCl pH 7.6). A gradient from 10 to 70% buffer Q-B (500 mM KCl, 20 mM Tris–HCl pH 7.6) was applied. Fractions containing Hp–Hb were pooled and ammonium sulphate added to 55% saturation. The sample was centrifuged at 27,000g for 15 min and loaded on a Source 15 Iso column (GE Healthcare) equilibrated with buffer Iso-A (55% ammonium sulphate, 20 mM Tris–HCl, pH 7.6). A gradient from 0 to 100% buffer Iso-B (20 mM Tris pH 7.6) was applied. Fractions containing Hp–Hb were pooled and concentrated using an Amicon Ultra centrifugal filter (10 kDa molecular mass cut-off (MWCO), Millipore). The sample was further purified using a Superdex 200 column (GE Healthcare) equilibrated in 75 mM KCl, 20 mM Tris–HCl pH 7.6. Fractions containing Hp–Hb were pooled and concentrated to 2 mg ml−1 using an Amicon Ultra centrifugal filter (10 kDa MWCO, Millipore).
Expression and purification of HpHbR wild type and mutants
The gene encoding the trypanosoma brucei brucei HpHbR (residues 36–378) was amplified (primer: 5′-CCCACGAATTCGCTGAGGGTTTAAAAACCAAAGACGAAGTTG-3′, primer: 5′-GATTTGCGGCCGCTTAACTAACCACGTCAACGGGCCTTGG-3′) and cloned into the EcoRI and NotI sites of the pPICZαA vector and transformed into the P. pastoris X33 cell line (Life technologies). Point mutations were introduced in the vector using the site-directed, ligase-independent mutagenesis method45. Colonies expressing recombinant HpHbR were inoculated in buffered glycerol-complex medium and incubated at 30 °C for 24 h. Cells were transferred to buffered methanol-complex medium and grown for 72 h at 30 °C. Protein expression was induced by adding 1.5% methanol every 12 h. Secreted HpHbR was purified from the medium by diluting 1:5 with 20 mM Tris–HCl pH 7.6 and loading on a Q Sepharose Fast Flow column (GE Healthcare) equilibrated in buffer Q-A (50 mM KCl, 20 mM Tris–HCl, pH 7.6). A gradient from 15 to 80% buffer Q-B (500 mM KCl, 20 mM Tris–HCl pH 7.6) was applied. Fractions containing HpHbR were pooled and concentrated using an Amicon Ultra centrifugal filter (10 kDa MWCO, Millipore). The sample was further purified using a Superdex 200 column (GE Healthcare) equilibrated in 75 mM KCl, 20 mM Tris–HCl, pH 7.6. HpHbR was deglycosylated by addition of 1/10 (w/w) endoglycosidase H and incubation overnight at 25 °C.
Expression and purification of IsdH NEAT1
The gene encoding IsdH NEAT1 (residues 86–229) with an N-terminal His-tag followed by a thrombin cleavage site was synthesized and cloned into the NdeI and BamHI sites of the pET-22b(+) vector (Genscript, Novagen). The vector was transformed into the BL21 rosetta Escherichia coli strain. Protein expression was induced with 1 mM IPTG. Cells were harvested and resuspended in lysis buffer (500 mM KCl, 20 mM Tris–HCl pH 7.6, 20 mM imidazole, 1 tablet Complete protease inhibitor (Roche Diagnostics GmBH) and 10% glycerol). The cells were opened by sonication (Branson Sonifier 250) and centrifuged 27,000 g for 20 min. Prior to loading on a Ni-column the samples were filtered through a 0.22-μm filter. The protein was eluted from the Ni-column with a gradient from 20–300 mM imidazole in a buffer containing 20 mM Tris–HCl pH 7.6, 500 mM KCl and 10% glycerol. Fractions containing IsdH were pooled and dialysed overnight against 75 mM KCl, 20 mM Tris–HCl pH 7.6 and 10% glycerol. The His-tag was removed by addition of 1/100 (w/w) thrombin and incubation overnight at 25 °C.
Formation and purification of the Hp–Hb–HpHbR–IsdH complex
Hp–Hb, HpHbR and IsdH NEAT1 were mixed in 1:2:2 molar ratios and incubated overnight at 4 °C. The sample was loaded on to a Superdex 200 column (GE healthcare) equilibrated in 75 mM KCl, 20 mM Tris–HCl, pH 7.6. Fractions containing the Hp–Hb–HpHbR–IsdH NEAT1 complex were pooled and concentrated to 10 mg ml−1 using an Amicon Ultra centrifugal filter (10 kDa MWCO, Millipore).
Crystallization and data collection
Crystals were obtained at 4 °C using the sitting-drop vapour diffusion method. Two μl protein sample (10 mg ml−1) was mixed with 2 μl reservoir solution containing 15% polyethylene glycol 1500 and 0.1 M Bis-Tris pH 6.0. The crystals were transferred to the cryoprotection buffer (40% polyethylene glycol 1500 and 0.1 M Bis-Tris pH 6.0) before being flash frozen in liquid nitrogen. X-ray diffraction data were collected at the XO6SA beamline (Swiss Light Source, Villigen, Switzerland) using a wavelength of 1.0 Å and at a temperature of 100 K. Data were indexed, integrated and scaled with the XDS package46. The crystals display P21 symmetry and diffract to a maximal resolution of 3.1 Å, However, the data are highly anisotropic with diffraction limit at ~4.5 Å on the c* axis47 (Table 1). The structure was solved by molecular replacement in PHASER48 with porcine Hp–Hb30, Hb–IsdH NEAT149 and T. congolense HpHbR7 as search models. Each asymmetric unit contains three dimeric Hp–Hb–HpHbR–IsdH complexes. Model building was done in the programs ‘O’50 and ‘Coot’51. Iterative refinement cycles were performed in PHENIX52. Atomic coordinates were restrained by tight sixfold non-crystallographic symmetry (one group for each monomeric unit of Hp–Hb–HpHbR–IsdH) with one B-factor group per residue throughout the refinement procedure. Figures were made using PYMOL53.
Formation and purification of the Hp–apoHb complex
Extraction of haem from Hb was achieved by acid-acetone precipitation54. Hb (5 mg ml−1) was slowly added to ice-cold acid acetone (5 ml of 5 M HCl per litre HPLC-grade acetone) in a 1:25 v/v ratio. After incubation for 1 h on ice, the sample was centrifuged at 25,000 g for 10 min. The pellet was resuspended in 0.1 M acetic acid and used for another round of precipitation. This was repeated until no more haem could be detected in the supernatant. At this point the precipitated apoHb was dissolved in buffer containing 150 mM NaCl, 4 mM CaCl2 and 10 mM HEPES pH 7.6. The sample was subsequently dialysed overnight against the same buffer. ApoHb was mixed with Hp in a 1:2 molar ratio and the Hp–apoHb complex purified using a Superdex 200 column (GE healthcare) equilibrated in 75 mM KCl and 20 mM Tris–HCl, pH 7.6. HoloHb was reconstituted by addition of 20 × molar excess of hemin prior to gelfiltration. Detection of haem was done by SDS–polyacrylamide gel electrophoresis and subsequent staining for peroxidase activity55 and by ultraviolet–vis absorption spectroscopy on a UltroSpec 3100 spectrophotometer (GE Healthcare).
Surface plasmon resonance
Binding studies were performed on a Biacore 3000 instrument (GE Healthcare GmbH). Immobilization was conducted in 10 mM sodium acetate pH 4.0 and remaining sites were blocked with 1 M ethanolamine pH 8.5. The signal generated for T.b. brucei HpHbR was 71.4 fmol mm−2 and 42.6 fmol mm−2 for Hp–Hb. Sample and flow buffer was 150 mM NaCl, 1.5 mM CaCl2, 1.0 mM EGTA, 0.005% Tween-20 and 10 mM HEPES pH 7.6. Sensor chips were regenerated with 500 mM NaCl, 20 mM EDTA and 10 mM glycine pH 4.0.
Additional information
Accession codes: Atomic coordinates and structure factors for the Hp–Hb–HpHbR–IsdH NEAT 1 complex have been deposited in the Protein Data Bank under accession code 4WJG.
How to cite this article: Stødkilde, K. et al. Structural basis for trypanosomal haem acquisition and susceptibility to the host innate immune system. Nat. Commun. 5:5487 doi: 10.1038/ncomms6487 (2014).
References
Simarro, P. P., Diarra, A., Ruiz Postigo, J. A., Franco, J. R. & Jannin, J. G. The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward. PLoS Negl. Trop. Dis. 5, e1007 (2011).
Mansfield, J. M. & Paulnock, D. M. Regulation of innate and acquired immunity in African trypanosomiasis. Parasite Immunol. 27, 361–371 (2005).
Pays, E., Vanhamme, L. & Pérez-Morga, D. Antigenic variation in Trypanosoma brucei: facts, challenges and mysteries. Curr. Opin. Microbiol. 7, 369–374 (2004).
Berriman, M. et al. The genome of the African trypanosome Trypanosoma brucei. Science 309, 416–422 (2005).
Vanhollebeke, B. et al. A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans. Science 320, 677–681 (2008).
Murray, M. & Dexter, T. M. Anaemia in bovine African trypanosomiasis. A review. Acta Trop. 45, 389–432 (1988).
Higgins, M. K. et al. Structure of the trypanosome haptoglobin-hemoglobin receptor and implications for nutrient uptake and innate immunity. Proc. Natl Acad. Sci. USA 110, 1905–1910 (2013).
Loveless, B. C. et al. Structural characterization and epitope mapping of the glutamic acid/alanine-rich protein from trypanosoma congolense. J. Biol. Chem. 286, 20658–20665 (2011).
Kristiansen, M. et al. Identification of the haemoglobin scavenger receptor. Nature 409, 198–201 (2001).
Stephens, N. A., Kieft, R., MacLeod, A. & Hajduk, S. L. Trypanosome resistance to human innate immunity: targeting Achilles' heel. Trends Parasitol. 28, 539–545 (2012).
Raper, J., Fung, R., Ghiso, J., Nussenzweig, V. & Tomlinson, S. Characterization of a novel trypanosome lytic factor from human serum. Infect. Immun. 67, 1910–1916 (1999).
Hajduk, S. L. et al. Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein. J. Biol. Chem. 264, 5210–5217 (1989).
Shiflett, A. M., Bishop, J. R., Pahwa, A. & Hajduk, S. L. Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes. J. Biol. Chem. 280, 32578–32585 (2005).
Maeda, N. Nucleotide sequence of the haptoglobin and haptoglobin-related gene pair. The haptoglobin-related gene contains a retrovirus-like element. J. Biol. Chem. 260, 6698–6709 (1985).
Bullard, W. et al. Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors. Virulence 3, 72–76 (2012).
Widener, J., Nielsen, M. J., Shiflett, A., Moestrup, S. K. & Hajduk, S. Hemoglobin is a co-factor of human trypanosome lytic factor. PLoS. Pathog. 3, 1250–1261 (2007).
Drain, J., Bishop, J. R. & Hajduk, S. L. Haptoglobin-related protein mediates trypanosome lytic factor binding to trypanosomes. J. Biol. Chem. 276, 30254–30260 (2001).
Pérez-Morga, D. et al. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309, 469–472 (2005).
Vanhollebeke, B. et al. Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum. Proc. Natl Acad. Sci. USA 104, 4118–4123 (2007).
Vanhollebeke, B., Lecordier, L., Pérez-Morga, D., Amiguet-Vercher, A. & Pays, E. Human serum lyses Trypanosoma brucei by triggering uncontrolled swelling of the parasite lysosome. J. Eukaryot. Microbiol. 54, 448–451 (2007).
Harrington, J. M., Howell, S. & Hajduk, S. L. Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein. J. Biol. Chem. 284, 13505–13512 (2009).
Uzureau, P. et al. Mechanism of Trypanosoma brucei gambiense resistance to human serum. Nature 501, 430–434 (2013).
Capewell, P. et al. The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense. PLoS Pathog. 9, e1003686 (2013).
Xong, H. V. et al. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95, 839–846 (1998).
Vanhamme, L. et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422, 83–87 (2003).
Kieft, R. et al. Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor. Proc. Natl Acad. Sci. USA 107, 16137–16141 (2010).
Symula, R. E. et al. Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance. PLoS Negl. Trop. Dis. 6, e1728 (2012).
DeJesus, E., Kieft, R., Albright, B., Stephens, N. A. & Hajduk, S. L. A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 binding. PLoS Pathog. 9, e1003317 (2013).
Wejman, J. C., Hovsepian, D., Wall, J. S., Hainfeld, J. F. & Greer, J. Structure and assembly of haptoglobin polymers by electron microscopy. J. Mol. Biol. 174, 343–368 (1984).
Andersen, C. B. F. et al. Structure of the haptoglobin-haemoglobin complex. Nature 489, 456–459 (2012).
Wejman, J. C., Hovsepian, D., Wall, J. S., Hainfeld, J. F. & Greer, J. Structure of haptoglobin and the haptoglobin-hemoglobin complex by electron microscopy. J. Mol. Biol. 174, 319–341 (1984).
Przybylska, M., Sheppard, H. M. & Szilágyi, S. Crystallization of the haptoglobin-hemoglobin complex. Acta Crystallogr. D Biol. Crystallogr. 55, 883–884 (1999).
Vickerman, K. On the surface coat and flagellar adhesion in trypanosomes. J. Cell. Sci. 5, 163–193 (1969).
Mehlert, A., Wormald, M. R. & Ferguson, M. A. J. Modeling of the N-glycosylated transferrin receptor suggests how transferrin binding can occur within the surface coat of Trypanosoma brucei. PLoS Pathog. 8, e1002618 (2012).
Schwede, A., Jones, N., Engstler, M. & Carrington, M. The VSG C-terminal domain is inaccessible to antibodies on live trypanosomes. Mol. Biochem. Parasitol. 175, 201–204 (2011).
Fedosov, S. N. et al. Mapping the functional domains of human transcobalamin using monoclonal antibodies. FEBS J. 272, 3887–3898 (2005).
Andersen, C. B. F., Madsen, M., Storm, T., Moestrup, S. K. & Andersen, G. R. Structural basis for receptor recognition of vitamin-B(12)-intrinsic factor complexes. Nature 464, 445–448 (2010).
Nielsen, M. J. et al. Haptoglobin-related protein is a high-affinity hemoglobin-binding plasma protein. Blood 108, 2846–2849 (2006).
Alayash, A. I., Andersen, C. B. F., Moestrup, S. K. & Bulow, L. Haptoglobin: the hemoglobin detoxifier in plasma. Trends Biotechnol. 31, 2–3 (2013).
Nielsen, M. J. et al. A unique loop extension in the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex. J. Biol. Chem. 282, 1072–1079 (2007).
Nielsen, M. J., Andersen, C. B. F. & Moestrup, S. K. CD163 binding to haptoglobin-hemoglobin complexes involves a dual-point electrostatic ligand-receptor pairing. J. Biol. Chem. 288, 18834–18841 (2013).
Andersen, C. B. F. & Moestrup, S. K. How calcium makes endocytic receptors attractive. Trends Biochem. Sci. 39, 82–90 (2014).
Alsford, S., Field, M. C. & Horn, D. Receptor-mediated endocytosis for drug delivery in African trypanosomes: fulfilling Paul Ehrlich’s vision of chemotherapy. Trends Parasitol. 29, 207–212 (2013).
Kennedy, P. G. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol. 12, 186–194 (2013).
Chiu, J., March, P. E., Lee, R. & Tillett, D. Site-directed, Ligase-Independent Mutagenesis (SLIM): a single-tube methodology approaching 100% efficiency in 4 h. Nucleic Acids Res. 32, e174 (2004).
Kabsch, W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Crystallogr. 26, 795–800 (1993).
Strong, M. et al. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 103, 8060–8065 (2006).
McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).
Krishna Kumar, K. et al. Structural basis for hemoglobin capture by Staphylococcus aureus cell-surface protein, IsdH. J. Biol. Chem. 286, 38439–38447 (2011).
Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Cryst. 47, (Pt 2): 110–119 (1991).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213–221 (2010).
Schrödinger, L. L. C. The PyMOL Molecular Graphics System, Version ~1.3r1 (2010).
Fanelli, A. R. et al. Studies on the structure of hemoglobin. I. Physicochemical properties of human globin. Biochim. Biophys. Acta 30, 608–615 (1958).
Stugard, C. E., Daskaleros, P. A. & Payne, S. M. A 101-kilodalton heme-binding protein associated with congo red binding and virulence of Shigella flexneri and enteroinvasive Escherichia coli strains. Infect. Immun. 57, 3534–3539 (1989).
Acknowledgements
We thank J.J. Jørgensen, Z. Binate A.M. Bundsgaard and G.P. Ratz for technical assistance, G.R. Andersen and A. Etzerodt for valuable discussions, F. Fredslund (MAX-lab) and V. Olieric (Swiss Light Source) for assistance with synchrotron data collection and E. Pays for plasmids. The research was supported by The Lundbeck Foundation, The Novo Nordisk Foundation, The European Research Council and The Danish Council for Independent Research (Sapere Aude programme).
Author information
Authors and Affiliations
Contributions
K.S. expressed, purified and crystallized the protein, collected and processed X-ray data and determined and refined the structure, assisted by M.T.-J. and C.B.F.A. Structural analysis was carried out by K.S. and C.B.F.A. K.S. performed the binding studies. S.K.M. and C.B.F.A. performed the study design and wrote the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Figures 1-9. (PDF 13391 kb)
Rights and permissions
About this article
Cite this article
Stødkilde, K., Torvund-Jensen, M., Moestrup, S. et al. Structural basis for trypanosomal haem acquisition and susceptibility to the host innate immune system. Nat Commun 5, 5487 (2014). https://doi.org/10.1038/ncomms6487
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/ncomms6487
This article is cited by
-
Heme-deficient metabolism and impaired cellular differentiation as an evolutionary trade-off for human infectivity in Trypanosoma brucei gambiense
Nature Communications (2022)
-
A Slam-dependent hemophore contributes to heme acquisition in the bacterial pathogen Acinetobacter baumannii
Nature Communications (2021)
-
Blood signatures for second stage human African trypanosomiasis: a transcriptomic approach
BMC Medical Genomics (2020)
-
Kinetics of cyanide and carbon monoxide dissociation from ferrous human haptoglobin:hemoglobin(II) complexes
JBIC Journal of Biological Inorganic Chemistry (2020)
-
Oxygen dissociation from ferrous oxygenated human hemoglobin:haptoglobin complexes confirms that in the R-state α and β chains are functionally heterogeneous
Scientific Reports (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.